In murine MLL-AF9—one of the most common MFPs with poor outcomes—AML model studies, depletion of either DNMT1 [22], KDM1A/LSD1 [23], or DOT1L [24–26] severely impaired leukemic transformation and disrupted disease progression. Here, MLLT3 is linked to acute myeloid leukemia.